Clinical Trial Update: FPA150 in Patients With Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial of FPA150 in breast cancer, ovarian cancer, and endometrial cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• FPA150

Snippet

Sponsor: Five Prime Therapeutics, Inc. | Conditions: Breast Cancer, Ovarian Cancer | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2024-11-22